当前位置：
X-MOL 学术
›
Transl. Neurodegener.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Parkinson’s disease in China: a forty-year growing track of bedside work
Translational Neurodegeneration ( IF 10.8 ) Pub Date : 2019-07-31 , DOI: 10.1186/s40035-019-0162-z Gen Li , Jianfang Ma , Shishuang Cui , Yixi He , Qin Xiao , Jun Liu , Shengdi Chen
Translational Neurodegeneration ( IF 10.8 ) Pub Date : 2019-07-31 , DOI: 10.1186/s40035-019-0162-z Gen Li , Jianfang Ma , Shishuang Cui , Yixi He , Qin Xiao , Jun Liu , Shengdi Chen
The number and health burden of Parkinson’s disease increase rapidly in China. It is estimated that China will have nearly half of the Parkinson’s disease population in the world in 2030. In this review, we present an overview of epidemiology and health economics status of Parkinson’s disease across China and discuss the risk factors of Parkinson’s disease and related complications. From the view of clinical research, we also discuss the current status of clinical trials, diagnostic biomarkers, treatment of Parkinson’s disease, tertiary network and post-occupation education in Chinese Parkinson’s disease clinics.
更新日期：2020-04-22
京公网安备 11010802027423号